Amprius Technologies, Inc.
No SEC Form 4 filings for $AMPX in the last 30 days.
See all $AMPX insider activity →Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.
Canaccord initiated coverage on Amprius Technologies (AMPX) with a Buy rating and $14 target, citing 144% revenue growth and market dominance. The company reported Q2 revenue of $34.02M, beating estimates, and raised full-year guidance. AMPX has a Strong Buy consensus with targets ranging from $18 to $30.
CAMINUS (formerly EnPower) has signed a contract manufacturing agreement with Amprius Technologies (NYSE: AMPX) to produce silicon-anode pouch cells at its Indianapolis facility. The deal covers partial assembly to full cell production, with volume production planned for 1Q27. Both companies emphasize the agreement's role in strengthening domestic battery supply chains for aviation, defense, and uncrewed systems.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning AMPX (Amprius Technologies, Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent AMPX coverage spans technology, financial news and insider activity.
Upward pressure as the market prices in new defense funding and near‑term volume from the Caminus partnership.
Positive catalyst from analyst initiation and sizable defense grant.
The agreement expands Amprius' production capability and may improve revenue visibility, supporting a positive outlook for the stock.
The grant provides significant non‑dilutive funding and validates Amprius' defense‑related battery technology, likely supporting near‑term share appreciation.
The grant secures future revenue and expands domestic manufacturing capacity, supporting near‑term price appreciation.
AlphAI scores every news story that mentions AMPX with an AI model for sentiment and relevance, and aggregates insider trades from Amprius Technologies, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.
2 min readCanaccord initiated coverage on Amprius Technologies (AMPX) with a Buy rating and $14 target, citing 144% revenue growth and market dominance. The company reported Q2 revenue of $34.02M, beating estimates, and raised full-year guidance. AMPX has a Strong Buy consensus with targets ranging from $18 to $30.
2 min readCAMINUS (formerly EnPower) has signed a contract manufacturing agreement with Amprius Technologies (NYSE: AMPX) to produce silicon-anode pouch cells at its Indianapolis facility. The deal covers partial assembly to full cell production, with volume production planned for 1Q27. Both companies emphasize the agreement's role in strengthening domestic battery supply chains for aviation, defense, and uncrewed systems.
1 min readAmprius (NYSE: AMPX) received a $75M grant from the U.S. Department of War to convert an EV battery line for high-energy density cells for drones. The $100M project, with a South Korean partner, aims to produce 12M cells annually by early 2028, meeting NDAA sourcing requirements.
2 min readAmprius Technologies (AMPX) shares rose 11% after receiving a $75M grant from the U.S. Department of War to convert a battery production line for unmanned aerial systems. The project, costing $100M, aims to produce 12M cells annually by early 2028, supporting NDAA-compliant domestic sourcing. The grant will expand Amprius' manufacturing capabilities in the U.S.
1 min readAmprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 23, 2026, Amprius Technologies, Inc. (the “Company”) entered into an Other Transaction Agreement (the “Agreement”) with the United States of America (the “U.S. Government”) for a project (“Project acCELLerate”) aw
2 min readAmprius Technologies (NYSE: AMPX) unveiled its second-gen SiCore battery, rated at 500 Wh/kg, for uncrewed electric aviation. The company claims it can be made with conventional lithium-ion manufacturing. Commercial availability is expected in Q4 2026. The tech may benefit high-altitude aircraft and drones, competing with SpaceX's Starlink satellites.
2 min readAmprius Technologies director Kang Sun sold 62,101 shares for $642,186 to cover tax obligations. The stock is down 4.2% this week. Amprius reported Q2 revenue of $34.02M, beating estimates, and raised its full-year revenue guidance to at least $140M. The company has $74.5M in cash and no debt.
2 min readSun Kang sold 62,101 shares of Amprius Technologies, Inc. (AMPX) at $10.34 ($0.64M total) on 2026-08-21.
1 min readStefan Constantin Ionel (Chief Technology Officer) sold 29,681 shares of Amprius Technologies, Inc. (AMPX) at $10.34 ($0.31M total) on 2026-08-21.
1 min read
